Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2025-12-26 @ 11:46 AM
Study NCT ID:
NCT04631016
Status:
COMPLETED
Last Update Posted:
2025-02-27
First Post:
2020-10-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-13
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-20
First Submit QC Date:
None
Study First Post Date:
2020-11-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-07
Results First Submit QC Date:
None
Results First Post Date:
2025-02-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-02-27
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-02-07
Last Update Post Date:
2025-02-27
Last Update Post Date Type:
ACTUAL